Adipose redistribution in human immunodeficiency virus-seropositive patients: association with CD4 response

Rebecca Wurtz, Sarah Ceaser

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

We have noted that human immunodeficiency virus (HIV)-seropositive patients who develop adipose redistribution (AR) while receiving combination antiretroviral therapy (ART) also tend to have a better response to ART, as indicated by the relative change in CD4 percent compared to those who don't develop AR on therapy. Whether the possible benefits of the improved CD4 response outweigh the metabolic and cosmetic problems associated with lipodystrophy is not known.

Original languageEnglish (US)
Pages (from-to)1497-1498
Number of pages2
JournalClinical infectious diseases: an official publication of the Infectious Diseases Society of America
Volume31
Issue number6
DOIs
StatePublished - Dec 2000

Fingerprint Dive into the research topics of 'Adipose redistribution in human immunodeficiency virus-seropositive patients: association with CD4 response'. Together they form a unique fingerprint.

  • Cite this